Endogenous hypercortisolism inducing reversible ocular hypertension
Purpose: To describe the clinical findings of two patients with reversible ocular hypertension secondary to endogenous hypercortisolism. Design: Retrospective, observational case series. Subjects: A 65-year-old man (patient 1) and a 21-year-old woman (patient 2) were both found to have Cushing'...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | American Journal of Ophthalmology Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451993619300982 |
id |
doaj-60230880368c4cdab2481617649b7113 |
---|---|
record_format |
Article |
spelling |
doaj-60230880368c4cdab2481617649b71132020-11-25T02:39:49ZengElsevierAmerican Journal of Ophthalmology Case Reports2451-99362019-12-0116Endogenous hypercortisolism inducing reversible ocular hypertensionShane Griffin0Timothy Boyce1Beth Edmunds2William Hills3Marjorie Grafe4Shandiz Tehrani5Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, OR, USACasey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, OR, USACasey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, OR, USACasey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, OR, USADepartment of Pathology, Oregon Health & Science University, Portland, OR, USACasey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, OR, USA; Corresponding author. 3375 SW Terwilliger Blvd., Portland, OR, 97239, USA.Purpose: To describe the clinical findings of two patients with reversible ocular hypertension secondary to endogenous hypercortisolism. Design: Retrospective, observational case series. Subjects: A 65-year-old man (patient 1) and a 21-year-old woman (patient 2) were both found to have Cushing's syndrome after presentation to our clinic with elevated intraocular pressures (IOP). Methods: Clinical histories, ophthalmic examinations including IOP measurements, optical coherence tomography of the retinal nerve fiber layer, visual field testing, magnetic resonance imaging and computerized tomography of two patients were reviewed between 2007 and 2019. Observations: Patient 1 demonstrated elevated IOP (maximum 26 mmHg OD and 22 mmHg OS) and bilateral disc edema. Following diagnosis of Cushing's syndrome, the patient underwent two pituitary resections and bilateral adrenalectomy, with subsequent resolution of his hypercortisolism and ocular hypertension (OHT). Patient 2 presented with blurred vision and found to have OHT (maximum 32 mmHg OU). Following diagnosis of Cushing's disease and two resections of her adrenocorticotropic hormone (ACTH) producing pituitary adenoma, her IOPs normalized. Both patients maintained normal IOPs after resolution of their endogenous hypercortisolism and discontinuation of topical IOP-lowering medication. Conclusions and Importance: Ocular hypertension induced by endogenous hypercortisolism is, in some cases, fully reversible following normalization of cortisol levels. These findings suggest that the physiologic changes to the trabecular meshwork induced by endogenous hypercortisolism may be fully reversible. Keywords: Ocular hypertension, Endogenous hypercortisolism, Glaucoma, Trabecular meshwork, Glucocorticoid, Cushing's syndromehttp://www.sciencedirect.com/science/article/pii/S2451993619300982 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shane Griffin Timothy Boyce Beth Edmunds William Hills Marjorie Grafe Shandiz Tehrani |
spellingShingle |
Shane Griffin Timothy Boyce Beth Edmunds William Hills Marjorie Grafe Shandiz Tehrani Endogenous hypercortisolism inducing reversible ocular hypertension American Journal of Ophthalmology Case Reports |
author_facet |
Shane Griffin Timothy Boyce Beth Edmunds William Hills Marjorie Grafe Shandiz Tehrani |
author_sort |
Shane Griffin |
title |
Endogenous hypercortisolism inducing reversible ocular hypertension |
title_short |
Endogenous hypercortisolism inducing reversible ocular hypertension |
title_full |
Endogenous hypercortisolism inducing reversible ocular hypertension |
title_fullStr |
Endogenous hypercortisolism inducing reversible ocular hypertension |
title_full_unstemmed |
Endogenous hypercortisolism inducing reversible ocular hypertension |
title_sort |
endogenous hypercortisolism inducing reversible ocular hypertension |
publisher |
Elsevier |
series |
American Journal of Ophthalmology Case Reports |
issn |
2451-9936 |
publishDate |
2019-12-01 |
description |
Purpose: To describe the clinical findings of two patients with reversible ocular hypertension secondary to endogenous hypercortisolism. Design: Retrospective, observational case series. Subjects: A 65-year-old man (patient 1) and a 21-year-old woman (patient 2) were both found to have Cushing's syndrome after presentation to our clinic with elevated intraocular pressures (IOP). Methods: Clinical histories, ophthalmic examinations including IOP measurements, optical coherence tomography of the retinal nerve fiber layer, visual field testing, magnetic resonance imaging and computerized tomography of two patients were reviewed between 2007 and 2019. Observations: Patient 1 demonstrated elevated IOP (maximum 26 mmHg OD and 22 mmHg OS) and bilateral disc edema. Following diagnosis of Cushing's syndrome, the patient underwent two pituitary resections and bilateral adrenalectomy, with subsequent resolution of his hypercortisolism and ocular hypertension (OHT). Patient 2 presented with blurred vision and found to have OHT (maximum 32 mmHg OU). Following diagnosis of Cushing's disease and two resections of her adrenocorticotropic hormone (ACTH) producing pituitary adenoma, her IOPs normalized. Both patients maintained normal IOPs after resolution of their endogenous hypercortisolism and discontinuation of topical IOP-lowering medication. Conclusions and Importance: Ocular hypertension induced by endogenous hypercortisolism is, in some cases, fully reversible following normalization of cortisol levels. These findings suggest that the physiologic changes to the trabecular meshwork induced by endogenous hypercortisolism may be fully reversible. Keywords: Ocular hypertension, Endogenous hypercortisolism, Glaucoma, Trabecular meshwork, Glucocorticoid, Cushing's syndrome |
url |
http://www.sciencedirect.com/science/article/pii/S2451993619300982 |
work_keys_str_mv |
AT shanegriffin endogenoushypercortisolisminducingreversibleocularhypertension AT timothyboyce endogenoushypercortisolisminducingreversibleocularhypertension AT bethedmunds endogenoushypercortisolisminducingreversibleocularhypertension AT williamhills endogenoushypercortisolisminducingreversibleocularhypertension AT marjoriegrafe endogenoushypercortisolisminducingreversibleocularhypertension AT shandiztehrani endogenoushypercortisolisminducingreversibleocularhypertension |
_version_ |
1724784592635822080 |